)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
Bora Pharmaceuticals (6472) investor relations material
Bora Pharmaceuticals Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary8 Aug, 2025
Executive summary
Achieved strong market cap of $2.9B, over 2,100 employees, and $600M+ in FY revenue for 02/2024, with 95% of revenues outside Taiwan.
Achieved second strongest EPS quarter historically, with significant growth in specialty and rare disease pipeline and double-digit market share gains in the Vigabatrin franchise.
Transitioned out of integration phase, evidenced by improved cash flow and balance sheet health.
Continued investment in high-value assets, DEE studies, and infrastructure, including new manufacturing capabilities in the US and Canada.
Consolidated financial statements for H1 2025 reviewed by independent auditors, with no material misstatements identified.
Financial highlights
Q2 2025 revenue reached NT$4,868mn, up 9% sequentially and 28% year-over-year; H1 2025 revenue was NT$9,347,370 thousand, up 28% year-over-year.
Gross margin for Q2 2025 at 41%, down from 42% in Q1 and 48% in H1 2024; H1 2025 gross margin was 42%.
Basic EPS for Q2 2025 was NT$5.95, with NT$1.81 from discontinued operations; core EPS excluding FX impacts reached NT$8.05.
Net income from continuing operations for H1 2025 was NT$3,572,795 thousand, up 38% year-over-year.
Operating cash inflow increased by ~NT$3,600mn year-over-year; ~NT$370mn debt paid down in Q2.
Outlook and guidance
Management is bullish for Q3 and Q4, expecting margin recovery as sterile production normalizes and Forex impact stabilizes.
Clear runway for organic growth in 2H25, with accelerating sales and net income expected.
CapEx investments in US facilities and operational synergies expected to drive further growth.
OpEx expected to remain controlled and lower in Q3 and Q4, similar to Q2.
The company continues to expand its CDMO and specialty pharma businesses through acquisitions and integration.
Assess impact of lower drug tariffs on US CDMO demand
Detail strategy for high-value branded drug growth
Identify key drivers for H2 gross margin recovery
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Bora Pharmaceuticals earnings date
Q3 202512 Nov, 2025
Next Bora Pharmaceuticals earnings date
Q3 202512 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
Bora Pharmaceuticals Co., Ltd. is active in the pharmaceutical industry, focusing on manufacturing and selling generic, brand, and over-the-counter drugs globally. The company spans the entire pharmaceutical supply chain from research and development to sales and distribution, offering services including contract development and manufacturing, consumer healthcare & OTC, and prescription drugs. Bora's facilities are certified by USFDA, MHRA, and PIC/S, ensuring the production of pharmaceuticals to the highest medical standards for distribution to over 100 countries worldwide. The company is headquartered in Taipei City, Taiwan, and its shares are listed on the Taiwan Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage